The multi-institutional project team will perform 1) a competitive landscape assessment around the company’s core programs to inform leadership of assets to surveil and 2) a survey of recently signed drug

The project team will evaluate and prioritize immuno-oncology and neuroscience applications for a novel whole-tissue imaging platform that enables rapid quantification of gene expression levels

The multi-institutional project team will perform due diligence on life science and therapeutics startups under consideration by a venture capital firm in the Bay Area. For each company, the team will evaluate

The multi-institutional project team will perform a survey to assess and prioritize oncological indications for a first-in-class small molecule inhibitor drug. The team will utilize primary and secondary research

The project team will evaluate the scientific landscape for a set of neurodevelopmental and neuropsychiatric diseases, and construct a therapeutic discovery plan that leverages the capabilities

The multi-institutional project team will evaluate the technical landscape and clinical readiness for a novel, off-the-shelf allogeneic immunotherapy. The team will utilize primary and secondary research